5 fat jab red flags after mum dies days after fake £20 'skinny jab'

Karen McGonigal's three daughters say she became "desperate" to lose weight after a long-term relationship ended - with ...
Investor's Business Daily on MSN

Can Penumbra's 'Landmark' Study Vs. Blood Thinners Change Guidelines?

Penumbra unveiled the results of a study on Sunday showing its device is superior to blood thinners in pulmonary embolism ...

Lilly's Omvoh (Mirikizumab-Mrkz) Approved By U.S. FDA As A Single-Injection Maintenance Regimen In Adults With Ulcerative Colitis

Approved By U.S. FDA As A Single-Injection Maintenance Regimen In Adults With Ulcerative Colitis. Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing th ...

Eli Lilly and Company: Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing ...

Pharmacist shares five warning signs your fat jab is FAKE after mother-of-two died

Karen McGonigal, 53, died days after she was illegally administered a dose of semaglutide - the powerful ingredient behind ...

The 5 red flags your fat jab is a FAKE after Brit mum dies from ‘skinny jab’ bought in salon

BRITS are being warned to watch out for fake fat jabs after a mum died from one she bought at a salon in Manchester. Karen ...

Eli Lilly Gets FDA Approval for Ulcerative Colitis Treatment Regimen

Eli Lilly said federal regulators have approved of a single-injection, once-monthly maintenance regimen in the U.S. for its ulcerative colitis treatment Omvoh.
Opinion
AllAfricaOpinion

Africa: Bridging the Innovation Divide - Making Modern Diabetes Care Accessible to All

Opinion - In South Africa, two people can live with the same chronic condition yet face vastly different realities.
Healthcare Packaging

Engineering Today’s Smart Packaging: An Evolution of Security and Connectivity

Technology is allowing for more intelligent package solutions. Integrating tools that will satisfy regulatory requirements ...

Eli Lilly and Company: Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic ...

New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the doses compared ...